FDA Approves Qelbree (viloxazine) as First New Children's ADHD Drug in 10 Years
TUESDAY, April 6, 2021 -- The first new drug developed in over a decade for children with attention deficit hyperactivity disorder (ADHD) has been approved by the U.S. Food and Drug Administration.
Qelbree, also known as viloxazine, comes in a...